Narwhal Capital Management Lowers stake in Amsurg Corp (AMSG)

Amsurg Corp (AMSG) : Narwhal Capital Management reduced its stake in Amsurg Corp by 3.01% during the most recent quarter end. The investment management company now holds a total of 16,085 shares of Amsurg Corp which is valued at $1,219,886 after selling 500 shares in Amsurg Corp , the firm said in a disclosure report filed with the SEC on Jul 26, 2016.Amsurg Corp makes up approximately 0.37% of Narwhal Capital Management’s portfolio.

Other Hedge Funds, Including , Smith Asset Management Group Lp boosted its stake in AMSG in the latest quarter, The investment management firm added 1,700 additional shares and now holds a total of 1,720 shares of Amsurg Corp which is valued at $130,445.Independent Portfolio Consultants reduced its stake in AMSG by selling 25 shares or 2.11% in the most recent quarter. The Hedge Fund company now holds 1,160 shares of AMSG which is valued at $91,570. Amsurg Corp makes up approx 0.03% of Independent Portfolio Consultants’s portfolio. Cutler Group Lp added AMSG to its portfolio by purchasing 1,215 company shares during the most recent quarter which is valued at $97,856. Amsurg Corp makes up approx 0.01% of Cutler Group Lp’s portfolio.

Amsurg Corp opened for trading at $73.95 and hit $75.145 on the upside on Friday, eventually ending the session at $75.01, with a gain of 0.98% or 0.73 points. The heightened volatility saw the trading volume jump to 10,49,034 shares. Company has a market cap of $4,110 M.

On the company’s financial health, Amsurg Corp reported $0.82 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on May 3, 2016. Analyst had a consensus of $0.78. The company had revenue of $724.70 million for the quarter, compared to analysts expectations of $702.21 million. The company’s revenue was up 27.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.62 EPS.

Many Wall Street Analysts have commented on Amsurg Corp. Company shares were Reiterated by Mizuho on Jun 24, 2016 to “Buy”, Firm has raised the Price Target to $ 95 from a previous price target of $90 .Amsurg Corp was Upgraded by BofA/Merrill to ” Buy” on Jun 16, 2016. Amsurg Corp was Initiated by Wells Fargo to “Market Perform” on Jun 15, 2016.

AmSurg Corp. is the owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology children’s services emergency medicine and radiology. The Company operates in two segments: ambulatory surgery services and outsourced physician services. The ambulatory services segment which acquires develops and operates ambulatory surgery centers in partnership with physicians. The physician services segment which provides outsourced physician services in multiple specialties to hospitals ambulatory surgery centers and other healthcare facilities primarily in the areas of anesthesiology children’s services emergency medicine and radiology. It operated approximately 246 ASCs in over 34 states and the District of Columbia in partnership with approximately 2000 physicians and provided physician services to over 320 healthcare facilities in 24 states.

Leave a Reply

Amsurg Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on Amsurg Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.